(Q40657286)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8004612 AND SRC:MED&resulttype=core&format=json

22 October 2019

review article

1 reference

title

Prognostic factors in early breast carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8004612 AND SRC:MED&resulttype=core&format=json

22 October 2019

author name string

E G Mansour

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8004612 AND SRC:MED&resulttype=core&format=json

22 October 2019

P M Ravdin

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8004612 AND SRC:MED&resulttype=core&format=json

22 October 2019

L Dressler

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8004612 AND SRC:MED&resulttype=core&format=json

22 October 2019

language of work or name

English

0 references

publication date

1 July 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8004612 AND SRC:MED&resulttype=core&format=json

22 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8004612 AND SRC:MED&resulttype=core&format=json

22 October 2019

volume

74

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8004612 AND SRC:MED&resulttype=core&format=json

22 October 2019

issue

1 Suppl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8004612 AND SRC:MED&resulttype=core&format=json

22 October 2019

page(s)

381-400

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8004612 AND SRC:MED&resulttype=core&format=json

A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma

22 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Cancer of the breast: Size of neoplasm and prognosis

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Patterns of relapse and survival following radical mastectomy.Analysis of 716 consecutive patients

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Nuclear characteristics as indicators of prognosis in node negative breast cancer patients

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Comparison of classic and quantitative prognostic factors in hormone receptor-positive and hormone receptor-negative female breast cancer

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Prognostic significance of peritumoral lymphatic and blood vessel invasion in node-negative carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Significance of estrogen and progesterone receptors, disease-free interval, and site of first metastasis on survival of breast cancer patients

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Prognostic value of estrogen and progesterone receptors in operable breast cancer. Results of a univariate and multivariate analysis

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Steroid receptors, cellular kinetics, and lymph node status as prognostic factors in breast cancer.

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

The long term prognostic significance of oestrogen receptor analysis in early carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Monoclonal antibodies localize oestrogen receptor in the nuclei of target cells

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Immunocytochemical detection of progesterone receptor in breast cancer with monoclonal antibody. Relation to biochemical assay, disease-free survival, and clinical endocrine response

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Immunocytochemical analysis of estrogen receptors in human breast carcinomas. Evaluation of 130 cases and review of the literature regarding concordance with biochemical assay and clinical relevance

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Abnormal estrogen receptor in clinical breast cancer

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

The prognostic value of immunohistochemical estrogen receptor analysis in paraffin-embedded and frozen sections versus that of steroid-binding assays

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Immunocytochemical estrogen and progestin receptor assays in breast cancer with monoclonal antibodies. Histopathologic, demographic, and biochemical correlations and relationship to endocrine response and survival

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast. Report of the DNA Cytometry Consensus Conference.

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Are DNA flow cytometry measurements providing useful information in the management of the node-negative breast cancer patient?

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Sequential cytopunctures during preoperative chemotherapy for primary breast carcinoma. Cytomorphologic changes, initial tumor ploidy, and tumor regression

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Sequential cytopunctures during preoperative chemotherapy for primary breast carcinoma. II. DNA flow cytometry changes during chemotherapy, tumor regression, and short-term follow-up

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Correlation of pretreatment proliferative activity of breast cancer with the response to cytotoxic chemotherapy

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Response to second-line hormone treatment for advanced breast cancer. Predictive value of ploidy determination

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

DNA flow cytometry in early breast cancer: a step in the right direction

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

DNA content measurement can be obtained using archival material for DNA flow cytometry. A comparison with cytogenetic analysis in 56 pediatric solid tumors

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Tissue-specific markers in flow cytometry of urological cancers. III. Comparing chromosomal and flow cytometric DNA analysis of bladder tumors

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

DNA content and genetic evolution of human colorectal adenocarcinoma. A study by flow cytometry and cytogenetic analysis

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

DNA ploidy and survival in breast cancer patients.

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Flow cytometric DNA index and S-phase fraction in breast cancer in relation to other prognostic variables and to clinical outcome

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Improving the prognostic value of DNA flow cytometry in breast cancer by combining DNA index and S-phase fraction: A proposed classification of DNA histograms in breast cancer

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Prognostic significance of DNA-ploidy in a series of 690 primary breast cancer patients

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Correlation of cell-cycle kinetics, hormone receptors, histopathology, and nodal status in human breast cancer

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Node-negative breast cancer: prognostic subgroups defined by tumor size and flow cytometry

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

The importance of DNA flow cytometry in node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

The relation of flow cytometry to clinical and biologic characteristics in women with node negative primary breast cancer

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Indicators of prognosis in node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

DNA flow cytometric analysis of primary operable breast cancer. Relation of ploidy and S-phase fraction to outcome of patients in NSABP B-04.

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Prognostic significance of flow cytometric DNA analysis in node-negative breast cancer patients

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Human breast cancer: identification of populations with a high risk of early relapse in relation to both oestrogen receptor status and c-erbB-2 overexpression

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Epidermal growth factor receptors and prognosis in breast cancer

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Stimulatory and inhibitory growth factors and breast cancer

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Epidermal-growth-factor receptors and oestrogen receptors in human breast cancer

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Epidermal growth factor receptor (EGFr); results of a 6 year follow-up study in operable breast cancer with emphasis on the node negative subgroup

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Epidermal growth factor receptors and prognosis in primary breast cancer

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Prognostic value of pS2 protein and receptors for epidermal growth factor (EGF-R), insulin-like growth factor-1 (IGF-1-R) and somatostatin (SS-R) in patients with breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Epidermal growth factor receptors in intracranial and breast tumours: their clinical significance

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Prognostic value of epidermal growth factor receptor in node-positive breast cancer

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Predictive value of EGF receptor in breast cancer

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Epidermal growth factor receptor expression as a prognostic indicator in breast cancer

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Prognostic value of epidermal growth factor receptor in a series of 303 breast cancers

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Human breast cancer: prognostic significance of the c-erbB-2 oncoprotein compared with epidermal growth factor receptor, DNA ploidy, and conventional pathologic features

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Expression of epidermal growth factor receptor in breast carcinoma

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Growth factor expression in Breast tissue

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Expression of epidermal growth factor receptors associated with lack of response to endocrine therapy in recurrent breast cancer

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

A secreted glycoprotein induced by estrogen in human breast cancer cell lines

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

The 52-kDa estrogen-induced protein secreted by MCF7 cells is a lysosomal acidic protease

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Cloning and Sequencing of the 52K Cathepsin D Complementary Deoxyribonucleic Acid of MCF7 Breast Cancer Cells and Mapping on Chromosome 11

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Phosphorylation, glycosylation, and proteolytic activity of the 52-kD estrogen-induced protein secreted by MCF7 cells

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Overexpression and hormonal regulation of pro-cathepsin D in mammary and endometrial cancer.

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Differential regulation of cathepsin D by sex steroids in mammary cancer and uterine cells

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Estrogens and growth factors induce the mRNA of the 52K-pro-cathepsin-D secreted by breast cancer cells

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Autocrine growth stimulation of the MCF 7 breast cancer cells by the estrogen-regulated 52 K protein.

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Interactions of cathepsin-D and insulin-like growth factor-II (IGF-II) on the IGF-II/mannose-6-phosphate receptor in human breast cancer cells and possible consequences on mitogenic activity of IGF-II

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Cathepsin D: a protease involved in breast cancer metastasis

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

MCF7 mammary cancer cells respond to bFGF and internalize it following its release from extracellular matrix: a permissive role of cathepsin D.

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Cathepsin D: an independent prognostic factor for metastasis of breast cancer

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Prognostic value of total cathepsin D in breast tumors. A possible role in selection of chemoresistant patients

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Prognostic relevance of cathepsin D versus oestrogen receptors in node negative breast cancers

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Multiparametric Prognostic Evaluation of Biological Factors in Primary Breast Cancer

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

A prospective study of the prognostic value of cathepsin D levels in breast cancer cytosol

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Prognostic significance of cathepsin-D in patients with breast cancer

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Cathepsin D expression detected by immunohistochemistry has independent prognostic value in axillary node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Prognostic significance of immunohistochemical analysis of cathepsin D in low-stage breast cancer

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Prognostic significance of the estrogen-regulated protein, cathepsin D, in breast cancer. An immunohistochemical study

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Cathepsin D and prognosis in breast cancer

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

What Is the Evidence That Tumors Are Angiogenesis Dependent?

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Novel growth regulatory factors and tumour angiogenesis

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Tumor behavior in isolated perfused organs: in vitro growth and metastases of biopsy material in rabbit thyroid and canine intestinal segment

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Induction of angiogenesis during the transition from hyperplasia to neoplasia

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Angiogenic Activity as a Marker of Neoplastic and Preneoplastic Lesions of the Human Bladder

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Regulation of tumor-host interactions in breast cancer

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

The p53 tumour suppressor gene

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Loss of heterozygosity on the short arm of chromosome 17 is associated with high proliferative capacity and DNA aneuploidy in primary human breast cancer

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

p53 function and dysfunction

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Regulation of transformation and the cell cycle by p53.

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Growth arrest induced by wild-type p53 protein blocks cells prior to or near the restriction point in late G1 phase

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Cancer. p53, guardian of the genome

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

p53 mutations: gains or losses?

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Nuclear p53 Immunoreaction Associated with Poor Prognosis of Breast Cancer

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Accumulation of p53 Tumor Suppressor Gene Protein: An Independent Marker of Prognosis in Breast Cancers

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Abnormal p53 immunoreactivity and prognosis in node-negative breast carcinomas with long-term follow-up

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Immunohistochemical detection of p53 protein in mammary carcinoma: An important new independent indicator of prognosis?

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

p53 protein expression in mammary ductal carcinoma in situ: Relationship to immunohistochemical expression of estrogen receptor and c-erbB-2 protein

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Immunochemical analysis of the p53 oncoprotein in matched primary and metastatic human tumours.

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Clinical relevance of the urokinase-type and tissue-type plasminogen activators and of their type 1 inhibitor in breast cancer

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Complete primary structure of the human estrogen-responsive gene (pS2) product

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

A new family of growth factor-like peptides. 'Trefoil' disulphide loop structures as a common feature in breast cancer associated peptide (pS2), pancreatic spasmolytic polypeptide (PSP), and frog skin peptides (spasmolysins).

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Prognostic relevance of pS2 status in association with steroid receptor status and proliferative activity in node-negative breast cancer.

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Clinical breast cancer, new developments in selection and endocrine treatment of patients

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Stress response protein (srp-27) determination in primary human breast carcinomas: clinical, histologic, and prognostic correlations

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Heat shock protein hsp70 in patients with axillary lymph node-negative breast cancer: prognostic implications

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Confirmation of a prognostic index for patients with metastatic breast cancer treated by endocrine therapy

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

The Nottingham prognostic index in primary breast cancer

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Proportional hazards and recursive partitioning and amalgamation analyses of the Southwest Oncology Group node-positive adjuvant CMFVP breast cancer data base: a pilot study

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

A practical application of neural network analysis for predicting outcome of individual breast cancer patients

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Factors predicting treatment responsiveness and prognosis in node-negative breast cancer. The International (Ludwig) Breast Cancer Study Group

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

RECPAM analysis of prognostic factors in patients with stage III breast cancer

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Breast cancer prognostic factors: evaluation guidelines.

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Predictive value of statistical models

1 reference

https://api.crossref.org/works/10.1002/CNCR.2820741326

7 January 2021

Identifiers

DOI

10.1002/CNCR.2820741326

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8004612 AND SRC:MED&resulttype=core&format=json

22 October 2019

1 reference